1–10 of 64 results for PDR
Aurora Borealis in Retina
Poornachandra B, MS, FVRS
Naresh Kumar Yadav, FRCS
Retina Image Bank: Images of the Week
2025
Who Stole My Blood Supply?
Muna Bhende, MD
Pramod S. Bhende, M S
Association Between DRSS Changes and Visual/ Anatomic Outcomes in Patients With Moderately Severe to Severe NPDR: Post Hoc Analysis of PANORAMA
Diana V Do, MD, FASRS
Annual Meeting Talks
2022
ASRS Updates in the Management of Diabetic Retinopathy DME and PDR in the Middle East and Africa
Sunir J. Garg, MD, FACS, FASRS
Webinars and Journal Clubs
2023
A Nightmare on PDR-TRD Street
On Demand Cases, Courses, and Papers
High risk Proliferative Diabetic Retinopathy treated with Pan Retinal Photocoagulation
Somnath Chakraborty, MD
Impact of Intravitreal Anti-VEGF Therapy for Severe Non-Proliferative Diabetic Retinopathy (NPDR): Analyses Through a Monte-Carlo Simulation Model
Andrew A. Moshfeghi, MD, MBA, FASRS
2021
Aflibercept Versus Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Hani Salehi-Had, MD
Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Automated Macular Vessel Density Quantification of Fluorescein Angiograms Among PDR Patients: Positive Correlation With Vision
Ajay E Kuriyan, MD, MS
2020